Bactericidal effect of S-nitrosothiols against clinical isolates from keratitis

Clinical Ophthalmology

Volumn 6, Issue 1, 2012, Pages 1907-1914

  Cariello, Angelino Julio ^a   Bispo, Paulo José Martins ^b   de Souza, Gabriela Freitas Pereira ^c   Pignatari, Antonio Carlos Campos ^b   de Oliveira, Marcelo Ganzarolli ^c   Hofling Lima, Ana Luisa ^a  

^a Department of Ophthalmology ^*  (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antimicrobial activity; Infectious keratitis; Nitric oxide donors; S nitroso N acetylcysteine; S nitrosoglutathione

Indexed keywords

N ACETYL S NITROSOCYSTEINE; S NITROSOGLUTATHIONE; S NITROSOTHIOL; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL KERATITIS; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG EFFICACY; DRUG STABILITY; DRUG SYNTHESIS; ENTEROBACTER AEROGENES; GROWTH INHIBITION; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; PSEUDOMONAS; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS;

EID: 84869767249     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S34830     Document Type: Article

References (36)

1. Whitcher J P, Srinivasan M, Upadhyay M P. Corneal blindness: a global perspective. Bull World Health Organ. 2001; 79: 214-221.
2. Ly CN, Pham JN, Badenoch PR, et al. Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fuoroquinolones and gentamicin plus cephalothin. Clin Exp Ophthalmol. 2006; 34: 44-50.
3. Kwatra D, Vadlapatla RK, Vadlapudi AD, Pal D, Mitra AK. Interaction of gatifoxacin with effux transporters: a possible mechanism for drug resistance. Int J Pharm. 2010;395: 114-121.
4. Yamada M, Yoshida J, Hatou S, Yoshida T, Minagawa Y. Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fuoroquinolones. Br J Ophthalmol. 2008; 92:848-851.
5. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327: 524-526.
6. Lockhart CJ, Gamble AJ, Rea D, et al. Nitric oxide modulation of ophthalmic artery blood fow velocity waveform morphology in healthy volunteers. Clin Sci. 2006;111: 47-52.
7. Grunwald JE, Iannaccone A, DuPont J. Effect of isosorbide mononitrate on the human optic nerve and choroidal circulations. Br J Ophthalmol. 1999;83:162-167.
8. Schmetterer L, Polak K. Role of nitric oxide in the control of ocular blood fow. Prog Retin Eye Res. 2001;20:823-847.
9. Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2001;2:907-916.
10. Hirst DG, Robson T. Nitrosative stress as a mediator of apoptosis: implications for cancer therapy. Curr Pharm Des. 2010;16:45-55.
11. Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol. 2004;2:820-832.
12. Stamler JS, Simon DI, Osborne JA, et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA. 1992;89:444-448.
13. de Souza GFP, Yokoyama-Yasunaka JKU, Seabra AB, Miguel DC, de Oliveira MG, Uliana SRB. Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: Implications for the treatment of cutaneous leishmaniasis. Nitric Oxide. 2006;15:209-216.
14. Abu-Shakra A. The mutagenic activity of the S-nitrosoglutathione/ glutathione system in Salmonella typhimurium TA1535. Mutat Res. 2003;539:203-206.
15. Flatley J, Barrett J, Pullan ST, Hughes MN, Green J, Poole RK. Transcriptional responses of Escherichia coli to S-nitrosoglutathione under defned chemostat conditions reveal major changes in methionine biosynthesis. J Biol Chem. 2005;280:10065-10072.
16. Cariello AJ, de Souza GFP, Foronda AS, Yu MCZ, Höfing-Lima AL, de Oliveira MG. In vitro amoebicidal activity of S-nitrosoglutathione and S-nitroso-N-acetylcysteine against trophozoites of Acanthamoeba castellanii. J Antimicrob Chemother. 2010;65:588-591.
17. Ehrt S, Shiloh MU, Ruan J, et al. A novel antioxidant gene from Mycobacterium tuberculosis. J Exp Med. 1997;186:1885-1896.
18. O'Brien L, Carmichael J, Lowrie DB, Andrew P W. Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect Immun. 1994;62:5187-5190.
19. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A6. Wayne, PA: Clinical and Laboratory Standards Institute; 2003.
20. Pacelli R, Wink DA, Cook JA, et al. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med. 1995;182:1469-1479.
21. Stevanin TM, Ioannidis N, Mills CE, Kim SO, Hughes MN, Poole RK. Flavohemoglobin Hmp affords inducible protection for Escherichia coli respiration, catalyzed by cytochromes bo' or bd, from nitric oxide. J Biol Chem. 2000;275:35868-35875.
22. Flint DH, Tuminello JF, Emptage MHJ. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. Biol Chem. 1993;268:22369-22376.
23. Keyer K, Imlay JA. Superoxide accelerates DNA damage by elevating free-iron levels. Proc Natl Acad Sci U S A. 1996;93:13635-13640.
24. Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 1997;99:2818-2825.
25. Ischiropoulos H, al-Mehdi AB. Peroxynitrite-mediated oxidative protein modifcations. FEBS Lett. 1995;364:279-282.
26. Schapiro JM, Libby SJ, Fang FC. Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress. Proc Natl Acad Sci U S A. 2003;100:8496-8501.
27. Lepoivre M, Fieschi F, Coves J, Thelander L, Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem Biophys Res Commun. 1991;179:442-448.
28. Juedes MJ, Wogan GN. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat Res. 1996;349:51-61.
29. Behar-Cohen FF, Goureau O, D'Hermies F, Courtois Y. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye. Invest Ophthalmol Vis Sci. 1996;37: 1711-1715.
30. Carreiro S, Anderson S, Gukasyan HJ, Krauss A, Prasanna G. Correlation of in vitro and in vivo kinetics of nitric oxide donors in ocular tissues. J Ocul Pharmacol Ther. 2009;25:105-112.
31. Cariello AJ, Souza GFP, Lowen MS, Nakayama SA, Oliveira M.G, Höfing-Lima AL. Assessment of in vivo ocular toxicity of nitric oxide donors compounds. Proceedings of ARVO Annual Meeting, Fort Lauderdale, FL, May 2-6, 2010. Invest Ophthalmol Vis Sci. 2010;51: Abstract 3123.
32. Brown MRW, Norton DA. The preservation of ophthalmic preparations. J Soc Cosmet Chem. 1965;16:369-393.
33. Nagai N, Murao T, Okamoto N, Ito Y. Comparison of corneal wound healing rates after instillation of commercially available latanoprost and travoprost in rat debrided corneal epithelium. J Oleo Sci. 2010;59: 135-141.
34. Roldán-Pallarés M, Avila MI, Refojo MF. The use of boric acid solution to help in the removal of biodegraded Miragel episcleral buckles. Retina. 2005;25:90-93.
35. Houlsby RD, Ghajar M, Chaves G. Microbiologic characteristics of unpreserved saline. J Am Optom Assoc. 1998;59:184-188.
36. Kikuchi T, Suzuki M, Kusai A, Iseki K, Sasaki H. Synergistic effect of EDTA and boric acid on corneal penetration of CS-088. Int J Pharm. 2005;290:83-89.